The Oncology Institute, Inc. shares rise 6.27% after-hours following Inka Health's selection by OneMedNet for AI-driven data analytics initiative.

The Oncology Institute, Inc. rose 6.27% in after-hours trading. The company's subsidiary, Inka Health, was selected by OneMedNet to lead a high-impact data analytics initiative focused on improving how cancer therapies are brought to market. This initiative leverages OneMedNet’s regulatory-grade patient data, including Radiology Imaging data, to develop external control arms (ECAs), which has the potential to accelerate the development timelines and costs of life-saving treatments.